C9orf72扩增、发病年龄与遗传祖先辅助区分FTLD行为变异型与语言变异型
该研究在泛欧洲FTLD队列(n=1396)中评估C9orf72扩增频率,并检验其与遗传祖先、发病年龄及综合征类型的关联。结果显示扩增携带者在bvFTD中显著多于PPA,中北欧祖先携带比例高于南欧祖先,扩增与中北欧祖先均与发病年龄独立负相关,基于三者的预测模型区分bvFTD的准确率为64%。
要点
- C9orf72扩增在FTLD-MND中占11.9%,bvFTD中占5%,PPA中仅占0.8%。
- bvFTD较PPA扩增携带比例显著更高(5% vs 0.8%,OR 6.4)。
- 扩增状态、遗传祖先与发病年龄联合预测bvFTD的准确率为64%。
核心结论
- 致病性C9orf72扩增、发病年龄与基于主成分分析的中北欧祖先同bvFTD诊断相关,提示行为变异型与语言变异型综合征由不同的复杂遗传风险架构支撑。
研究设计与样本
- 研究为泛欧洲FTLD队列研究,共纳入1396例,其中bvFTD 800例、PPA 495例、FTLD-MND 101例。
- 统计方法包括Fisher精确检验、方差分析及Tukey事后检验、logistic回归和非线性混合效应模型回归。
主要发现
- 全部病例中C9orf72致病性扩增占4%(56/1396)。
- 扩增携带者分布为:FTLD-MND 12/101(11.9%)、bvFTD 40/800(5%)、PPA 4/495(0.8%)。
- bvFTD较PPA扩增携带比例显著更高(5% vs 0.8%,p=2.17×10-5,OR 6.4,CI 2.31-24.99)。
- 中北欧祖先者较南欧祖先者扩增携带比例显著更高(4.4% vs 1.8%,p=1.1×10-2,OR 2.5,CI 1.17-5.99)。
- 致病性扩增与中北欧祖先均独立且与发病年龄呈负相关;预测模型诊断bvFTD的准确率为64%。
临床怎么用
- 在FTLD综合征鉴别中,可结合C9orf72扩增状态、遗传祖先背景与发病年龄辅助区分bvFTD与PPA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to characterize C9orf72 expansions in relation to genetic ancestry and age at onset (AAO) and to use these measures to discriminate the behavioral from the language variant syndrome in a large pan-European cohort of frontotemporal lobar degeneration (FTLD) cases. METHODS: We evaluated expansions frequency in the entire cohort (n = 1,396; behavioral variant frontotemporal dementia [bvFTD] [n = 800], primary progressive aphasia [PPA] [n = 495], and FTLD-motor neuron disease [MND] [n = 101]). We then focused on the bvFTD and PPA cases and tested for association between expansion status, syndromes, genetic ancestry, and AAO applying statistical tests comprising Fisher exact tests, analysis of variance with Tukey post hoc tests, and logistic and nonlinear mixed-effects model regressions. RESULTS: We found C9orf72 pathogenic expansions in 4% of all cases (56/1,396). Expansion carriers differently distributed across syndromes: 12/101 FTLD-MND (11.9%), 40/800 bvFTD (5%), and 4/495 PPA (0.8%). While addressing population substructure through principal components analysis (PCA), we defined 2 patients groups with Central/Northern (n = 873) and Southern European (n = 523) ancestry. The proportion of expansion carriers was significantly higher in bvFTD compared to PPA (5% vs 0.8% [p = 2.17 × 10-5; odds ratio (OR) 6.4; confidence interval (CI) 2.31-24.99]), as well as in individuals with Central/Northern European compared to Southern European ancestry (4.4% vs 1.8% [p = 1.1 × 10-2; OR 2.5; CI 1.17-5.99]). Pathogenic expansions and Central/Northern European ancestry independently and inversely correlated with AAO. Our prediction model (based on expansions status, genetic ancestry, and AAO) predicted a diagnosis of bvFTD with 64% accuracy. CONCLUSIONS: Our results indicate correlation between pathogenic C9orf72 expansions, AAO, PCA-based Central/Northern European ancestry, and a diagnosis of bvFTD, implying complex genetic risk architectures differently underpinning the behavioral and language variant syndromes.
引用
- Costa B, Manzoni C, Bernal-Quiros M, et al. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts. Neurology. 2020. PMID: 32943482. doi:10.1212/WNL.0000000000010914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。